Jeannie Chern, MD, discusses challenges with germline molecular testing for patients with ovarian cancer.
Jeannie Chern, MD
Advertisement
Articles by Jeannie Chern, MD
Jeannie Chern, MD, a gynecologic oncologist at Moffitt Cancer Center, discusses important germline and somatic mutations to be aware of in ovarian cancer.
Advertisement
Latest Updated Articles
Dr. Chern on Important Germline and Somatic Mutations in Ovarian CancerFebruary 17th 2020
Advertisement
Advertisement
Trending on OncLive
1
Dr Cercek on the FDA Approval of Dostarlimab for dMMR/MSI-H Locally Advanced Rectal Cancer
2
Weigh Benefit Against Burden: Defining Lurbinectedin’s Role in a Shifting Small Cell Lung Cancer Landscape
3
Vilamakitug Meets OS Threshold in Phase 1/2 Refractory mCRC Trial
4
Dr Warren on the Goal of the 4WARD Trial Evaluating Mavorixafor in Chronic Neutropenia
5